Loading clinical trials...
Loading clinical trials...
Observational Study in Healthy Subjects and Patients With COPD to Assess the Relationship Between Clinical, Imaging and Biomarker Measurements, and Progression of Emphysema Over Three Years [FOOTPRINTS®].
Conditions
Locations
51
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California San Diego
San Diego, California, United States
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, United States
National Jewish Health
Denver, Colorado, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
April 13, 2016
Primary Completion Date
June 14, 2021
Completion Date
June 14, 2021
Last Updated
August 16, 2024
NCT06712563
NCT06831994
NCT02755974
NCT02796937
NCT05087641
NCT05050591
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions